Stempeutics out licenses its stem cell product to Cipla for treating Diabetic Foot Ulcer
Under this agreement, Cipla will get the exclusive marketing rights for five years in India for DFU product with Stempeutics…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Manipal Education and Medical Group
Stempeutics receives Japan process patent for its stem cell drug ‘Stempeucel’
Stempeucel is derived from allogeneic pooled mesenchymal stromal cells extracted from the bone marrow of healthy, adult voluntary…
Stempeutics receives ATMP classification from EMA for its novel stem cell drug Stempeucel
The first stem cell drug-based on pooling technology to be granted ATMP classification Stempeutics Research, a group company of…